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Abstract: Development of the atherosclerotic plaque involves a complex interplay 
between a number of cell types and an extensive inter-cellular communication via cell 
bound as well as soluble mediators. The family of tribbles proteins has recently been 
identified as novel controllers of pro-inflammatory signal transduction. The objective of 
this study was to address the expression pattern of all three tribbles proteins in 
atherosclerotic plaques from a mouse model of atherosclerosis. Each tribbles were 
expressed in vascular smooth muscle cells, endothelial cells as well as in resident 
macrophages of mouse atherosclerotic plaques. The role of IL-1 mediated inflammatory 
events in controlling tribbles expression was also addressed by inducing experimental 
atherosclerosis in ApoE/IL1R1/ (double knockout) mice. Immunohistochemical 
analysis of these mice showed a selective decrease in the percentage of trb-1 expressing 
macrophages, compared to the ApoE/ cohort (14.7%  1.55 vs. 26.3%  1.19). The 
biological significance of this finding was verified in vitro where overexpression of trb-1 in 
macrophages led to a significant attenuation (~70%) of IL-6 production as well as a 
suppressed IL-12 expression induced by a proinflammatory stimulus. In this in vitro 
setting, expression of truncated trb-1 mutants suggests that the kinase domain of this 
protein is sufficient to exert this inhibitory action.  
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1. Introduction 
Atherosclerosis arises as a result of chronic inflammation of the artery wall, which occurs in 
response to a wide range of different stimuli, including fatty diets. The generation of atherosclerotic 
plaques involves a complex interplay between various vascular cell types and cytokine signalling 
networks. Although the molecular events that initiate the development of atherosclerotic lesions are 
still somewhat unclear, a large body of evidence supports a role for low-density lipoproteins (LDL), 
free radicals, infections [1], immune responses and biomechanical stress [2]. Many of the signals 
generated are processed via the mitogen activated protein kinase (MAPK) cascades, which are well 
known for acting as molecular controllers of cellular behaviour and their activation can lead to a 
diverse set of cellular functions. In particular, JNK kinases [3] and p38 kinases [4] have been shown to 
be highly active in smooth muscle cells (VSMC) in atherosclerotic lesions. In this context, MAPK 
activation is a substantial driver of plaque development as it promotes the production of pro-
inflammatory cytokines and matrix metalloproteinases, induces the chemotactic migration of VSMC 
and monocytes as well as promoting VSMC proliferation. Therefore, intervention strategies with a 
clinical utility, which modulate plaque development via inhibiting MAPK pathways, are being 
sought continuously. 
In recent years, a family of negative regulators of MAPK and PI3K cascades, called tribbles (trb) 
have emerged. These are evolutionally conserved, kinase-like proteins; their catalytic domain is 
missing some of the conserved residues thought to be indispensable for kinase activity [5]. They have 
been shown to interact with several transcription factors (reviewed in [5]) as well as MAPK-kinases 
(MKKs) [6] and Akt [7]. A controlling role for tribbles has been implicated in cell division [8,9] as 
well as in hormone induced cellular responses, including insulin [10] and pro-inflammatory 
cytokines [6]. 
Human genetic evidence suggests that trb-1 may be a risk factor in the development of hyperlipidemia 
and cardiovascular disease [11], whilst trb-3 has been linked to insulin resistance and type 2 diabetes [12]. 
In addition to these studies, our group has recently characterised the potential functional role of 
tribbles in key vascular cell types, vascular smooth muscle cells [13] and monocytes [14]. These 
experiments demonstrated that trb-1 controls the proliferation rate and chemotaxis of VSMC via 
interaction with the MAPK kinase, MKK4. Trb-2 is a key controller of inflammatory activation of 
monocytes and its’ expression is controlled by modified LDL. We have shown that trb-1 is expressed 
primarily in the intimal region of human atherosclerotic arteries, whilst Deng and colleagues have 
recently reported that trb-2 may be overexpressed in macrophages resident in unstable regions of 
atherosclerotic plaques, based on correlative quantitative PCR data [15]. 
However, whilst an important regulatory function for tribbles in vascular cell inflammation is 
supported by a number of studies and some expression data is available for individual tribbles 
homologues, no systematic study investigating the expression of the tribbles protein family has been 
performed in atherosclerosis. 




In the study presented here, we have characterised the expression profile of all three mammalian 
tribbles in the ApoE/ murine experimental model of atherosclerosis. We have also identified the 
potential regulation of tribbles expression by IL-1, a master cytokine involved in atherosclerotic plaque 
development, in vivo. Our data demonstrate that smooth muscle cells and plaque resident macrophages 
express all three tribbles proteins. Using an Apo E/IL-1R double deficient mouse [16], we show that 
trb-1 expression in the macrophages is largely IL-1 dependent. In vitro studies confirm this finding, 
using Raw 267.4 mouse macrophages and show that trb-1 expression is elevated in response to LPS, a 
proinflammatory stimulus that signals via a largely identical set of signalling pathways to IL-1, and 
that this protein controls LPS induced IL-6 production in these cells. 
2. Results and Discussion 
2.1. Trb 1 Expression in Mouse Atherosclerotic Lesions 
We have previously reported a selective increase in trb-1 expression in human aortic vascular 
smooth muscle cells within human atherosclerotic lesions compared to non-diseased aorta [13]. 
However, there is very limited information published to date on the expression of other tribbles in 
diseased arteries at the protein level. Therefore, we have studied here the expression pattern of trb-1, -2 
and -3 in mouse atherosclerosis by immunostaining lesions obtained from the aortic root of fat-fed 
animals. Mice were fed a Western-type diet for 8 weeks whereupon they develop significant and 
complex lesions throughout the arterial tree as previously described [16]. Aortic root lesions were 
immunostained for trb-1 positive cells. In some sections, lesions were also stained for smooth muscle 
cells and macrophages. 
Figure 1 shows the pattern of trb-1 expression in the aortic root of ApoE/ mice fed an atherogenic 
diet for 8 weeks.  
The majority of trb-1 protein is detected as expected in the medial region (Figure 1A and B) and in 
the fibrous cap (Figure 1A and C). When dual immunostaining is performed, the majority of trb-1 
expression co-localises with smooth muscle actin (Figure 1E and F, trb-1 (brown)/actin (red)). In 
addition, some cells, particularly in the plaque areas express trb-1 but are not smooth muscle cells 
(Figure 1F). 
Numerous macrophages and some large plaques are also routinely detected in the aortic roots of  
fat-fed ApoE/ mice ([16] and Figure 2A). It is apparent that numerous trb-1 stained macrophages 
(macrophage (red), trb-1 (brown)) are present in these areas with a high plaque burden (Figure 2A 
shows trb1 staining alone, Figure 2B dual staining and 2C and 2D dual high power staining). The 
macrophage index—the number of macrophages/total number of cells × 100 in a 100 micron squared 
area of atherosclerotic plaque—for the vessel wall in these experiments was 51.3  4.1%, n = 5.  
In addition, the percentage of macrophages expressing trb-1 in the aortic roots in this model was  
26.3  1.19%, n = 5. The remaining medial cells positive for trb1 but which are not macrophages are 
most likely to be smooth muscle cells. 
 
 




Figure 1. Tribbles 1 (trb-1) expression in experimental mouse atherosclerosis. A Trb1 
expression (brown) in the aortic sinus P (plaque), E (endothelium); B High power of boxed 
inset from A, P (plaque); C Trb-1 expression in endothelium, some macrophages (arrows); 
D negative control (secondary Ab only); E dual staining for trb-1 (brown) and Smooth 
Muscle Cell Actin (red); F as E with some trb staining in endothelium (arrows). Note: 
some cells express trb-1 but not SMA and are probably macrophages. 
 
 




Figure 2. Tribbles 1 expression in macrophages in experimental mouse atherosclerosis.  
A Single immunostaining for trb-1 (brown) in a section from the aortic sinus, B Dual 
immunostaining of a serial section to A for trb1 (brown) and macrophages (Gal3, red), note 
areas of plaque stained red; trb-1 expressing macrophages are denoted by arrows. C and D, 
high power images of other representative plaques showing most macrophages stain 
positive for trb-1 in fat-fed ApoE deficient mice. 
 
2.2. Trb2 Expression in Mouse Atherosclerotic Lesions 
We have already shown that trb-2 is expressed in smooth muscle cells and endothelial cells cultured 
in vitro and that this changes little under conditions of inflammatory stimulation [17]. Recently, a role 
for trb-2 was proposed by Deng et al. in regulating cytokine expression in macrophages, resident in 
unstable plaques [15]. In line with this, we have shown that acetylated LDL potentiates LPS-induced 
IL-8 production in human monocytes [14]. Modified lipid downregulates trb-2 expression, leading to 
enhanced activation of ERK and JNK MAPK pathways. This, in turn, leads to a selective increase in 
IL-8 expression.  




In the stable mouse atherosclerotic lesions investigated here, trb-2 appeared to be weakly expressed 
(Figure 3A, B) in smooth muscle cells and some macrophages (Figure 3C and D). Expression in 
adipose tissue in the adventitial area was also noted (Figure 3D). 
Figure 3. Tribbles 2 (trb2) expression in experimental mouse atherosclerosis. A Trb-2 
expression in the aortic sinus, P, (plaque), M (media), E (endothelium); B high power of A, 
M (media), macrophages (arrows); C another high power image of a plaque (P) showing 
trb-2 expression in the media; D trb2 staining in the adventitial region of the aortic sinus to 
show positive staining in adipose tissue (arrows).  
 
2.3. Trb3 Expression in Mouse Atherosclerotic Lesions 
In vitro, trb-3 is constitutively expressed in smooth muscle cells and endothelial cells and is induced 
up-to 6 fold after LPS stimulation [17]. Further, upregulation of trb-3 has been shown in hypoxia [18] 
and cellular stress [19]. However, the tissue distribution of this protein in the atherosclerotic vessel 
wall is currently unknown. In mouse atherosclerotic lesions, positive trb-3 staining was observed in 
smooth muscle cells (Figure 4A) and macrophages predominantly (Figure 4C). 
 




Figure 4. Tribbles 3 staining in experimental mouse atherosclerosis. A Dual staining of 
trb-3 (brown) and macrophages (Gal3); B negative control (secondary Ab only); C dual 
staining as A to show some coincident trb-3 and macrophage staining to show an equal 
proportion of trb3 in macrophages and VSMC. 
 
2.4. Expression of Trbs in Mouse Atherosclerotic Lesions in the Absence of IL-1 Signalling 
Since IL-1 is known to be critical in the development of atherosclerosis in mice [16,20] and IL-1 
expression mirrors raised expression of trb-1 in vascular smooth muscle cells in vitro [13], we 
investigated whether the spatial expression of trbs were altered in atherosclerotic lesions from 
ApoE/IL1R1/ (DN) mice. We immunostained aortic root samples from DN mice after fat feeding 
for 8 weeks and determined the extent of trb expression in relevant cell types. There were no 
significant changes in expression of trb-2 and trb-3 in the absence of IL-1 signalling in the context of 
atherosclerosis (data not shown).  
However, in lesions from DN mice analysed for trb-1 positive staining, there were significantly less 
trb-1 positive macrophages/0.1mm2 of plaque than in ApoE/ animals (14.7%  1.55, n = 4 compared 
with 26.3%  1.19 [ApoE/], n = 5) (Figure 5E). Representative Figures 5A-C show that there are 
considerably less macrophages (red) that co-stain for trb-1 (brown) in aortic root plaques from 
ApoE/IL-1R1/ mice than from controls (Figures 5D) fed the same diet (Figure 2). The percentage 
of macrophages compared to the total number of cells within lesions was unchanged between the two 
strains 53  4.1 ApoE/ vs. 42  6 (ApoE/IL-1R1/) (n = 4  5, p = NS) as has been described 
previously [16]. In addition, we have not observed a substantial change in trb-1 expression in VSMC 
and endothelial cells between the two strains. 
2.5. Tribbles-1 is a Negative Regulator of IL-6 Production and its’ Expression is Up-Regulated by IL-1 
in Macrophages in vitro 
In order to investigate the biological significance of tribbles-1 expression levels in macrophages (as 
seen in the ApoE/ aortic roots) and to determine if this was generally controlled by TIR receptor 
mediated inflammatory stimuli, first we established whether the Raw 264.7 macrophage cell line 
recapitulated our in vivo findings (Figures 2 and 5). Raw 264.7 cells were stimulated by LPS for 24 hrs 
and the expression of trb-1 was determined by western blot. We chose LPS as an agonist in these 
experiments as Raw 264.7 cells are well known to be highly responsive to this proinflammatory 




compound. In addition, LPS signals through signalling pathways similar to those induced by IL-1.  
As the data in Figure 6A show, trb-1 expression is upregulated under these conditions. 
Figure 5. Macrophage tribbles 1 expression is reduced in experimental atherosclerosis in 
mice lacking the ability to signal via the IL-1 receptor. A and B, aortic plaques from 
ApoE/IL-1R1/ mice. Macrophages (red), trb-1 (brown). Note: the non-coincident 
staining for trb1 and macrophages in these sections in comparison to Figure 2; C and D, 
high power to show fewer macrophages positive for trb-1 in plaques than seen in plaques 
from ApoE/ mice (Figures 1 and 2). E Quantitation of Trb 1 expressing macrophages per 
0.1 mm2 of aortic root plaque in ApoE / vs. ApoE/IL-1R1/ mice.  
 




Next, the functional consequences of overexpressed trb-1 were tested in Raw 264.7 cells, transfected 
with a trb-1 expression construct. Transfected cells were then stimulated with LPS and IL-6 production 
examined by ELISA. Our results demonstrate that overexpressed trb-1 strongly inhibits the production 
of IL-6 in macrophages (Figure 6B). Expression of truncated trb-1 mutants, lacking the proline rich  
N-terminal (aa 1-92) or the C-terminal (aa 338-372) region—as described before [21]—suggest that 
the kinase-like domain of this protein sufficient to exert inhibitory action. This is in line with our 
previously published mechanistic data on tribbles action [6,13]. To further elucidate the importance of 
trb-1 in the inflammatory activation of macrophages, Raw 264.7 cells were transfected with a 
luciferase reporter, driven by the promoter of the IL-12 gene, and the impact of an increasing dose of 
overexpressed trb-1 on LPS induced IL-12 expression was investigated. In line with the proposed role 
for trb-1 as an anti-inflammatory molecule, LPS induced IL-12 expression was abrogated in response 
to overexpressed trb-1. 
Figure 6. Trb-1 expression is induced by LPS and this protein controls IL-6 production in 
Raw 267.4 macrophages. A. Raw 264.7 cells were stimulated with 100 ng/mL LPS for  
24 hrs and expression of trb-1 was monitored by western blot. As a loading control, 
expression of beta actin was determined, by stripping the membrane after probing for trb-1 
and re-probing for the housekeeping control gene. A representative blot is shown from 
three independent experiments, with identical results. B. Raw 264.7 cells were stimulated 
24 hrs post-transfection with 20 ng/mL LPS for 6 hrs and IL-6 expression measured in the 
media by ELISA. Three independent experiments were performed, with three biological 
replicates each time. As no IL-6 expression was observed in the absence of LPS treatment, 
only stimulated samples are shown. Expression levels were normalised to the mean value 
in the mock-transfected treatment for each experiments and the normalised data were 
pooled for statistical analysis. One-way ANOVA was performed to assess statistical 
significance of the results. ** p < 0.001. C. Raw 264.7 cells were transfected with an  
IL12-luciferase reporter in the presence or absence of overexpressed trb-1 and the 
activation of the reporter by LPS was monitored. One-way ANOVA was performed to 
assess statistical significance of the results. * p < 0.05. 
 





Molecular control of cellular function is achieved via the coordinated action of key intracellular 
signal processing systems. A number of these, including the MAPK signalling network and PI3K 
driven signal transduction pathways have been the subject of intense research in connection to 
cardiovascular disease and their potential as targets for therapeutic intervention [22,23]. 
The contribution of MAPK pathways has been elucidated recently. It has been shown that 
scavenger receptor (CD36) mediated signalling, triggered by oxLDL, is transmitted via src tyrosine 
kinases (lyn) and MAPK kinase kinase kinase (MAPKKK) proteins. Blocking lyn or JNK signalling 
via pharmacological inhibitors led to attenuated foam cell formation [24]. Atherosclerosis studies in 
gene deficient mice showed that JNK2 but not JNK1 deficiency led to reduced plaque size [25]. It has 
been suggested that this is due to the blockade of foam cell development via impaired scavenger 
receptor signalling. Similar to JNK, p38 has also been suggested to play a role in the control of CD36 
mediated foam cell formation [24]. 
Cellular activation via the family of PI3K proteins has also been investigated in the context of 
atherosclerosis. Specifically, PI3K and  have been shown to control T cell migration, production of 
reactive oxygen species (ROS) in macrophages in response to proinflammatory stimuli, the secretion 
of proinflammatory cytokines, including IL-1 and IL-6 as well as activation of mast cells and platelet 
function [23].  
The regulation of the MAPK and PI3K signalling pathways by tribbles family members is now well 
established [6,26]. However, very little is known about the expression profile of specific tribbles in 
atherosclerotic plaques, their contribution to disease development and the mechanisms that control 
tribbles expression in this setting.  
To address these issues, we performed a systematic analysis of the expression pattern of all three 
mammalian tribbles in the ApoE/ fat-fed model of atherosclerosis and show that these proteins are 
present in smooth muscle cells, endothelial cells and plaque resident macrophages.  
IL-1 is widely appreciated as a major contributor of plaque development in atherosclerosis. In line 
with this, ApoE/IL-1R double knockout mice are protected from atherosclerosis, compared to ApoE/ 
controls [16]. Given previous findings that tribbles-1 expression correlates with induction of IL-1 
expression in vascular cells and that the expression of this gene family is regulated by inflammatory 
stimuli in a cell-type specific manner, we hypothesised that elimination of the IL-1 driven 
inflammatory stimulus (by knocking out the IL-1 receptor) would modulate tribbles expression in 
atherosclerotic plaques. This is shown in this study selectively for macrophage specific expression of 
tribbles-1. Based on these data and the above literature, we propose that tribbles-1 is expressed in 
plaque resident macrophages as part of an IL-1 induced negative feedback mechanism to control the 
extent of inflammatory activation of these cells. Our in vitro data support this model and suggests a 
negative regulatory role for this protein in the expression of proinflammatory cytokines in 
macrophages. This concurs with phenotypic analysis of macrophages from trb-1 deficient mice, which 
display an enhanced proinflammatory response to LPS [27]. We surmise therefore that impaired 
tribbles-1 expression in vivo due to genetic variations in the human population may sensitise 
macrophages to inflammatory stimuli and that this could contribute to the development of chronic 
inflammatory disease. 




Our observations may provide a mechanistic explanation for the rapidly increasing genetic evidence 
that trb-1 is a significant risk factor in cardiovascular disease [28,29]. Whilst the molecular 
mechanisms for such a role are still not well understood, two lines of supporting evidence have been 
put forward. First, genome wide association studies (GWAS) identified trb-1 as a risk factor in 
hyperlipidaemia and MI [28] and, second, Ostertag revealed that trb-1 is a critical controller of 
inflammatory responses in adipocytes [30]. In both settings, reduced tribbles-1 accompanied elevated 
inflammatory responses, agreeing with our proposed model of trb-1 mediated control of cellular 
homeostasis. 
Tribbles-2 and -3 have also been detected in specific cells of the plaque. A recent study published 
by Deng et al [15] suggested that trb-2 expression in plaque resident macrophages correlated with 
plaque vulnerability and this may be of functional importance in the onset of ACS. Whilst our 
experiments were not designed to address this question (the majority of plaques were stable), we did 
detect the expression of trb-2 in macrophage-like cells in the plaque core. This is in agreement with 
data showing that oxLDL induced upregulation of trb-3 expression in monocyte-derived macrophages [31].  
In addition to macrophages and smooth muscle cells, recent reports have suggested a role for 
tribbles in the control of adipocyte function [26,30,32]. We routinely detected expression of tribbles in 
adipocyte-like cells in the far adventitial area of vessels lending some observational support to these 
previous findings.  
4. Experimental Section
4.1. Animals 
ApoE/ mice (stock no. 002052) and IL-1R1/ (stock no. 3245) were obtained from the Jackson 
Laboratories; ApoE/ IL-1R1/ double deficient mice were generated by cross-breeding. All mice 
were on a C57BL/6 background and fed normal ‘chow’ (4.3% w/v fat, 0.02% w/v cholesterol) or 
‘Western’ (18.5% w/v fat, 0.9% w/v cholesterol, 0.5% w/v cholate) diet. Animals were housed in a 
controlled environment with a 12 hour light/dark cycle at 22 °C. All experiments were performed in 
accordance with UK legislation under the 1986 Animals (Scientific Procedures) Act, and approval was 
granted by the University ethics review board. The investigation conforms with the Guide for the Care 
and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication 
No. 85-23, revised 1996).  
4.2. Cell Culture 
Raw 264.7 cells (ATCC: TIB-71) were cultured in standard media and treated with of LPS, as 
specified in the appropriate figure legends.  
4.3. Western Blot, ELISA 
Trb-1 protein was detected using a trb-1 antibody (Millipore) diluted 1:500 in 0.05% v/v Tween 
20/5% v/v non-fat milk as previously described [13]. Briefly, membranes were blocked in 0.05% v/v 
Tween 20/5% v/v non-fat milk for 2 hours at RT, then incubated overnight at 4ºC with a polyclonal 
trb-1 specific antibody (Millipore 09-126) diluted 1:500 in blocking buffer, and detected by a  




HRP-conjugated goat anti-rabbit IgG secondary antibody (Dako, P0448). Membranes were developed 
with SuperSignal West Pico chemiluminescent substrate, and signals were quantified by Chemigenius 
gel documentation system (Syngene). 
ELISA was performed to quantify the production of mouse IL-6 (R&D systems), as recommended 
by the manufacturer. 
4.4. Immunohistochemistry 
Paraffin-embedded sections of aortic sinus were stained immunohistochemically for smooth muscle 
actin (Dako, M0851, 1:150) to visualize vascular smooth muscle cells and Galectin-3 (R&D, AF1197, 
1:50) to visualize macrophages. Trb antibodies used were: trb-1 (Millipore, 09-126) at 1:125, trb-2 
(Sigma, HPA001305) at 1:200 and trb-3 (Millipore) at 1:200. 
Standard immunohistochemical techniques were applied. 
4.5. Analysis of Trb Expression in Atherosclerotic Lesions 
The number of different types of cells expressing trbs was assessed by morphometric measurement 
of histologically stained paraffin-embedded sections using a Lucia image analysis software system 
(Lucia G, Nikon, UK). The total and positively stained cell nuclei were counted within a fixed area. 
The values reported represent a mean from at least 5 sections for each animal.  
5. Conclusions
In summary, this is the first systematic study of tribbles expression in experimental atheroma and 
the data suggest an important regulatory function for tribbles-1 in vascular cell pathophysiology. In 
addition, our data clearly demonstrate that inflammatory signals selectively control the expression of 
trb-1 in plaque macrophages, suggesting that this may be an important homeostatic control mechanism 
to modulate the inflammatory phenotype of these cells. 
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